skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Effect of angiotensin II blockade on central blood pressure and arterial stiffness in subjects with hypertension

Review

(1596) Views  (481) Full article downloads

Authors: Michel E Safar

Published Date December 2010 Volume 2010:3 Pages 167 - 174
DOI: http://dx.doi.org/10.2147/IJNRD.S6664

Michel E Safar
Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Hôtel-Dieu Centre de Diagnostic et de Thérapeutique, Paris, France

Abstract: In hypertension, the blood pressure curve may be divided into two sets of components. The first set is mean arterial pressure, steady flow, and vascular resistance, thus acting on small arteries; the second set refers to large arteries, hence to pulse pressure, arterial stiffness, and wave reflections. The angiotensin-converting enzyme (ACE) inhibitor perindopril not only reduces mean arterial pressure but also acts specifically on pulse pressure. The effect on pulse pressure predominates on central rather than peripheral (brachial) large arteries, reducing aortic stiffness and most wave reflections. Such hemodynamic changes are not observed with standard ß-blockade, which reduces aortic stiffness and brachial systolic and pulse pressure but not central pulse pressure and wave reflections. In hypertensive subjects, perindopril and other ACE inhibitors seem to predict more consistently the reduction of cardiovascular events, mainly of cardiac origin, than standard ß-blockers alone. This effect is associated with the important biochemical finding that mechanotransductions of angiotensin and ß-blockade are markedly different, acting in the former specifically on the α5ß1 integrin complex and on the fibronectin ligand of arterial vessels.

Keywords: antihypertensive therapy, arterial stiffness, renal function




 

Other articles by Professor Michel Safar



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
Update on the diagnosis and management of acute kidney injury
New and improved strategies for the treatment of gout
Community-based health efforts for the prevention of falls in the elderly
VEGF 936C>T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less
Personal best times in an Olympic distance triathlon and in a marathon predict Ironman race time in recreational male triathletes
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Emerging drug combinations to optimize renovascular protection and blood pressure goals
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio